Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy

Clinical trial NCT03118349 · TERMINATED

Trial details

NCT number

NCT03118349

Sponsor

BioNTech Research & Development, Inc.

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-06-01

Primary completion

2018-04-11

Enrollment

4

View on ClinicalTrials.gov